Hedgepath, LLC Files Lawsuit Alleging Self-Dealing in Hedgepath Pharmaceuticals, Inc. by Its Controlling Stockholder
Lawsuit alleges self-dealing in Hedgepath Pharmaceuticals, Inc. by its controlling stockholder, an indirect subsidiary of Mayne Pharma Group Ltd. with estimated damages exceeding $800,000,000. - July 23, 2019
HedgePath LLC Challenges Fairness of HPPI Commercial License
HedgePath LLC, founder of HedgePath Pharmaceuticals, Inc. (OTC: HPPI) Challenges the Fairness of the Commercial License for the BCCNS Indication Granted by HPPI to the Controlling, Majority Shareholder. - January 03, 2019
Press Releases 1 - 2 of 2